Change of Director's Interest Notice - David Trimboli
director_dealing announcement
Latest articles and price-sensitive announcements with AI sentiment classification.
director_dealing announcement
director_dealing announcement
other announcement
Highlights TRI has released a fresh disclosure centred on a Stabl Im clinical development update. The development places the company within the broader Healthcare Stocks category and gives the ticker a company-specific news angle. The latest disclosure establishes a current clinical development checkpoint, while further progress depends on subsequent company communication and evidence. The Australian share market is constantly processing fresh corporate announcements, and healthcare upda...
other announcement
Why Is TrivarX (ASX:TRI) Stock Facing Selling Pressure Today? Kalkine
other announcement

Trivarx believes that radiopharmacy has an important place in medical imaging - but its radiation-free tool can enhance this age-old ... Read More The post Biocurious: Trivarx hones the radiation-free approach to cancer oncology appeared first on Stockhead.
other announcement

TrivarX has secured the investigational product supply required to initiate a Phase I clinical feasibility trial of its Stabl-Im imaging ... Read More The post TrivarX secures key supply for Stabl-Im imaging clinical trial appeared first on Stockhead.

Tylah Tully sits down with TrivarX incoming CEO Dr Danielle Meyrick. ... Read More The post Long Shortz with TrivarX: Next-gen imaging targets earlier cancer detection appeared first on Stockhead.